114 related articles for article (PubMed ID: 18053639)
1. Low hMLH1 expression prior to definitive chemoradiotherapy predicts poor prognosis in esophageal squamous cell carcinoma.
Nam TK; Lee JH; Cho SH; Chung IJ; Ahn SJ; Song JY; Yoon MS; Chung WK; Nah BS
Cancer Lett; 2008 Feb; 260(1-2):109-17. PubMed ID: 18053639
[TBL] [Abstract][Full Text] [Related]
2. Expression of the murine double minute gene 2 oncoprotein in esophageal squamous cell carcinoma as a novel marker for lack of response to chemoradiotreatment.
Ikeguchi M; Ueda T; Fukuda K; Yamaguchi K; Tsujitani S; Kaibara N
Am J Clin Oncol; 2002 Oct; 25(5):454-9. PubMed ID: 12393983
[TBL] [Abstract][Full Text] [Related]
3. Association of p53 expression with prognosis in patients with esophageal squamous cell carcinoma.
Yao W; Qin X; Qi B; Lu J; Guo L; Liu F; Liu S; Zhao B
Int J Clin Exp Pathol; 2014; 7(10):7158-63. PubMed ID: 25400812
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylated mammalian target of rapamycin expression is associated with the response to chemoradiotherapy in patients with esophageal squamous cell carcinoma.
Li SH; Huang EY; Lu HI; Huang WT; Yen CC; Huang WC; Chen CH
J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1352-9, 1359.e1. PubMed ID: 22841170
[TBL] [Abstract][Full Text] [Related]
5. Murine double minute 2 predicts response of advanced esophageal squamous cell carcinoma to definitive chemoradiotherapy.
Okamoto H; Fujishima F; Kamei T; Nakamura Y; Ozawa Y; Miyata G; Nakano T; Katsura K; Abe S; Taniyama Y; Sakurai T; Teshima J; Hikage M; Sasano H; Ohuchi N
BMC Cancer; 2015 Mar; 15():208. PubMed ID: 25880782
[TBL] [Abstract][Full Text] [Related]
6. p16INK4a hypermethylation and p53, p16 and MDM2 protein expression in esophageal squamous cell carcinoma.
Taghavi N; Biramijamal F; Sotoudeh M; Khademi H; Malekzadeh R; Moaven O; Memar B; A'rabi A; Abbaszadegan MR
BMC Cancer; 2010 Apr; 10():138. PubMed ID: 20388212
[TBL] [Abstract][Full Text] [Related]
7. Bax expression as a prognostic marker of postoperative chemoradiotherapy for patients with esophageal cancer.
Ikeguchi M; Maeta M; Kaibara N
Int J Mol Med; 2001 Apr; 7(4):413-7. PubMed ID: 11254884
[TBL] [Abstract][Full Text] [Related]
8. Combined analysis of p53 and retinoblastoma protein expressions in esophageal cancer.
Ikeguchi M; Oka S; Gomyo Y; Tsujitani S; Maeta M; Kaibara N
Ann Thorac Surg; 2000 Sep; 70(3):913-7. PubMed ID: 11016333
[TBL] [Abstract][Full Text] [Related]
9. An immunohistochemical study of p16, pRb, p21 and p53 proteins in human esophageal cancers.
Kato H; Yoshikawa M; Fukai Y; Tajima K; Masuda N; Tsukada K; Kuwano H; Nakajima T
Anticancer Res; 2000; 20(1A):345-9. PubMed ID: 10769678
[TBL] [Abstract][Full Text] [Related]
10. Relationship between the epithelial expression of hMLH1, MDM2, and p63 and lower lip carcinogenesis.
de Oliveira DH; de Sousa Lopes ML; de Santana Sarmento DJ; Queiroz LM; da Costa Miguel MC; da Silveira EJ
J Oral Pathol Med; 2014 May; 43(5):357-63. PubMed ID: 24329813
[TBL] [Abstract][Full Text] [Related]
11. Differential diagnosis of atypical epithelium of biopsied gastric mucosa using immunostaining of Ki-67, p53, hMLH1 and MDM2 expression.
Ito E; Saito K; Takizawa T; Koike M
J Exp Clin Cancer Res; 2002 Dec; 21(4):527-37. PubMed ID: 12636099
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors of radiotherapy in patients with node-positive thoracic esophageal squamous cell carcinoma after radical surgery.
Lu JC; Tao H; Chen ZZ; Qian PD
Dis Esophagus; 2009; 22(6):490-5. PubMed ID: 19191849
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor is a possible predictor of sensitivity to chemoradiotherapy in the primary lesion of esophageal squamous cell carcinoma.
Gotoh M; Takiuchi H; Kawabe S; Ohta S; Kii T; Kuwakado S; Katsu K
Jpn J Clin Oncol; 2007 Sep; 37(9):652-7. PubMed ID: 17940077
[TBL] [Abstract][Full Text] [Related]
14. Expression of p21(Waf1/Cip1) predicts response and survival of esophageal cancer patients treated by chemoradiotherapy.
Nakamura T; Hayashi K; Ota M; Ide H; Takasaki K; Mitsuhashi M
Dis Esophagus; 2004; 17(4):315-21. PubMed ID: 15569370
[TBL] [Abstract][Full Text] [Related]
15. Promoter methylation of the hMLH1 gene and protein expression of human mutL homolog 1 and human mutS homolog 2 in resected esophageal squamous cell carcinoma.
Tzao C; Hsu HS; Sun GH; Lai HL; Wang YC; Tung HJ; Yu CP; Cheng YL; Lee SC
J Thorac Cardiovasc Surg; 2005 Nov; 130(5):1371. PubMed ID: 16256791
[TBL] [Abstract][Full Text] [Related]
16. Concurrent erlotinib and radiotherapy for chemoradiotherapy-intolerant esophageal squamous cell carcinoma patients: results of a pilot study.
Zhai Y; Hui Z; Wang J; Zou S; Liang J; Wang X; Lv J; Chen B; Zhu H; Wang L
Dis Esophagus; 2013 Jul; 26(5):503-9. PubMed ID: 22862289
[TBL] [Abstract][Full Text] [Related]
17. Correlation of p53, MDM2 and p14(ARF) protein expression in human esophageal squamous cell carcinoma.
Cheng TH; Hsu PK; Li AF; Hung IC; Huang MH; Hsu HS
J Cancer Res Clin Oncol; 2009 Nov; 135(11):1577-82. PubMed ID: 19488782
[TBL] [Abstract][Full Text] [Related]
18. The expression of murine double minute 2 is a favorable prognostic marker in esophageal squamous cell carcinoma without p53 protein accumulation.
Saito H; Tsujitani S; Oka S; Ikeguchi M; Maeta M; Kaibara N
Ann Surg Oncol; 2002 Jun; 9(5):450-6. PubMed ID: 12052755
[TBL] [Abstract][Full Text] [Related]
19. Expression of epidermal growth factor receptor and proliferating cell nuclear antigen predicts response of esophageal squamous cell carcinoma to chemoradiotherapy.
Hickey K; Grehan D; Reid IM; O'Briain S; Walsh TN; Hennessy TP
Cancer; 1994 Sep; 74(6):1693-8. PubMed ID: 7915963
[TBL] [Abstract][Full Text] [Related]
20. The molecular markers for prognostic evaluation of areca-associated buccal squamous cell carcinoma.
Liu CJ; Chang KW; Chao SY; Kwan PC; Chang SM; Yen RY; Wang CY; Wong YK
J Oral Pathol Med; 2004 Jul; 33(6):327-34. PubMed ID: 15200480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
